Incidence of presumed endophthalmitis after intravitreal injection performed in the operating room: a retrospective multicenter study.

PURPOSE: To evaluate the incidence of presumed endophthalmitis (EO) after intravitreal injection (IVI) of anti-vascular endothelial growth factor agents performed in the operating room. METHODS: Retrospective study at 2 Swiss eye hospitals between 2004 and 2012. Hospital records were used to identify patients treated with an IVI of an anti-vascular endothelial growth factor agent between 2004 and 2012 and those treated for EO, defined as any intraocular inflammation treated with intravitreal antibiotics. All IVIs were performed using standard sterile technique in a Swiss Class 1 operating room. No patient received preinjection topical antibiotics. Postinjection topical antibiotics were used only in one hospital. RESULTS: A total of 40,011 IVIs were performed at the 2 centers during the study period. Of the IVIs, ranibizumab was injected in 36,398 (91%), bevacizumab in 3,518 (9%), aflibercept in 89 (0.2%), and pegaptanib in 6 (<0.1%). Three cases of post-IVI presumed EO occurred, yielding a combined incidence of 0.0075% per injection (95% confidence interval: 0.0026-0.0220%) or 1 case per 13,337 IVIs. Two of the three cases of EO occurred in patients using post-IVI antibiotics. All three cases followed ranibizumab injection and were culture negative by anterior chamber tap or vitreous biopsy. CONCLUSION: The risk of EO after IVI performed under the sterile conditions of the operating room was very low.

Stroke campaign - Leaflet, posters and wallet card

The F.A.S.T materials (poster/leaflet/wallet card) convey the signs and symptoms of stroke, and the call to action, that it's a medical emergency to call 999 immediately if you see any one of these signs. A fast response to the signs and symptoms of stroke can reduce the long term health consequences such as disability and death. Attached below are the�public information leaflets (male and female version), posters and wallet card available as part of the campaign.

Temporal distribution of dengue virus serotypes in Colombian endemic area and dengue incidence: re-introduction of dengue-3 associated to mild febrile illness and primary infection

We have investigated the temporal distribution of dengue (DEN) virus serotypes in the department (state) of Santander, Colombia, in relation to dengue incidence, infection pattern, and severity of disease. Viral isolation was attended on a total of 1452 acute serum samples collected each week from 1998 to 2004. The infection pattern was evaluated in 596 laboratory-positive dengue cases using an IgG ELISA, and PRNT test. The dengue incidence was documented by the local health authority. Predominance of DEN-1 in 1998 and DEN-3 re-introduction and predominance in 2001-2003 coincided with outbreaks. Predominance of DEN-2 in 2000-2001 coincided with more dengue hemorrhagic fever (DHF). DEN-4 was isolated in 2000-2001 and 2004 but was not predominant. There was an annual increase of primary dengue infections (from 13.7 to 81.4%) that correlated with frequency of DEN-3 (r = 0.83; P = 0.038). From the total number of primary dengue infections DEN-3 (81.3%) was the most frequent serotype. DHF was more frequent in DEN-2 infected patients than in DEN-3 infected patients: 27.5 vs 10.9% (P < 0.05). DEN-3 viruses belonged to subtype C (restriction site-specific-polymerase chain reaction) like viruses isolated in Sri-Lanka and other countries in the Americas. Our findings show the importance of continuous virological surveillance to identify the risk factors of dengue epidemics and severity.

Preventing infections caused by Pseudomonas - Parent/Carer Information leaflet

Information for parents on preventing infections caused by Pseudomonas

Screening patients for Pseudomonas - Parent/Carer Information leaflet

Information leaflet for parents and carers on screening patients for Pseudomonas.

Splenectomy patient leaflet

This leaflet is for patients who have no functioning spleen. It explains their condition and outlines some important information that patients with no functioning spleen need to know.�

Ovarian cancer leaflet

This booklet has been reproduced and distributed in Northern Ireland to raise awareness of the signs and symptoms of ovarian cancer among women. Ovarian cancer is often diagnosed at a late stage but the sooner it is detected the easier it is to treat. The original leaflet produced by Target Ovarian Cancer is available in other languages at: www.targetovariancancer.org.uk http://www.targetovariancancer.org.uk/about-ovarian-cancer/what-ovarian-...

Walk Leader information leaflet

The Walking for Health programme was established in 2001 and continues to be an integral part of Government policy to address the health and wellbeing of the population in Northern Ireland. The programme is delivered through HSC Trusts across Northern Ireland and is supported by the Public Health Agency. Walking for Health aims to encourage inactive people to increase their level of physical activity by participating in local led health walks.

Shingles leaflet - Aged 70 or 78

The vaccine will be phased in over the next few years.�All people�aged 70 on 1 September 2015 will be�offered the vaccine, as well as those�aged 78 on 1 September 2015.�

Healthy breaks for schools leaflet (English and Irish)

Guidance on healthy breaks for schoolchildren. (Translations revised March 2014)

Healthy breaks for pre-school children leaflet (English and Irish translation)

Leaflet for parents explaining why a healthy break is so important for pre-school children and some tips and ideas for healthy nutritious breaks.�

Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO) Screening Information leaflet

Information for patients being screened for Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO)

Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO) Patient Information leaflet

Information for patients and visitors on�Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO)

Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO) staff information leaflet

This leaflet contains information for healthcare workers on�Carbapenemase Producing Enterobacteriaceae/Carbapenemase Producing Organism (CPE/CPO)

'Speak up and save a life' organ donation leaflet

Speak up and save a life leaflet and registration form - See more at: http://organdonationni.info/resources#sthash.fJpwUrw6.dpuf